Erasmo de la Pena-Almaguer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Erasmo de la Pena-Almaguer has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Juan Carlos Ibarrola-Peña
Escuela de Medicina y Ciencias de la Salud, Tecnologico de Monterrey, Monterrey 64710, Nuevo Leon, Mexico
4 shared publications - Carlos Jerjes-Sanchez
Escuela de Medicina y Ciencias de la Salud, Tecnologico de Monterrey, Monterrey 64710, Nuevo Leon, Mexico
3 shared publications - José Gildardo Paredes-Vázquez
Escuela de Medicina y Ciencias de la Salud, Tecnologico de Monterrey, Monterrey 64710, Nuevo Leon, Mexico
3 shared publications - Daniel Lira-Lozano
Escuela de Medicina y Ciencias de la Salud, Tecnologico de Monterrey, Monterrey 64710, Nuevo Leon, Mexico
2 shared publications - Jose Alfredo Salinas-Casanova
Escuela de Medicina y Ciencias de la Salud, Tecnologico de Monterrey, Monterrey 64710, Nuevo Leon, Mexico
2 shared publications - Anthony Peduto
Department of Radiology, Westmead Hospital; Faculty of Health Sciences, The University of Sydney, Australia
1 shared publication
Latest Publications
- 29 October 2026
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 135, 295-306
Sex-Related Variation in Abdominal Aortic Dimensions and the Effect of Body Size Indexing: A Computed Tomography Study in Mexican Adults
- 29 October 2026
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 135, 295-306
Sex-Related Variation in Abdominal Aortic Dimensions and the Effect of Body Size Indexing: A Computed Tomography Study in Mexican Adults
- Open Access
- 2 March 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 10 (3)
Unmasking Brugada syndrome: a case report of diagnostic oversights
Background: Brugada syndrome (BrS) is an unusual cardiac channelopathy associated with an increased risk of ventricular fibrillation (VF) and sudden cardiac death (SCD), highlighting the critical importance of early diagnosis. Case summary: A 22-year-old male patient presented with recurrent episodes of syncope, palpitations, and dyspnoea. Initial electrocardiograms (ECGs) showing a Brugada Type 1 pattern were misinterpreted as incomplete right bundle branch blocks. The patient was erroneously diagnosed with epilepsy due to misinterpretation of his syncope episodes as seizures. After further investigations, including a propafenone provocation test and cardiac magnetic resonance imaging (MRI), BrS was confirmed. An electrophysiologic study showed no inducibility of ventricular tachycardia (VT) or VF, and a subcutaneous implantable cardioverter-defibrillator (S-ICD) was implanted for the prevention of SCD. The patient’s recovery was successful and uncomplicated. Discussion: Brugada syndrome patients usually present with SCD, syncope, or severe arrhythmias. Syncope is the most common clinical presentation and identifies patients who could benefit from ICD. Only the Type 1 Brugada pattern is diagnostic, either spontaneous, unmasked by high precordial leads, or by sodium channel inhibition. Implantable cardioverter-defibrillator placement is indicated to prevent SCD. A subcutaneous defibrillator should be considered if the patient has no need for anti-bradyarrhythmia pacing. Conclusion: Early recognition of BrS in patients with syncope is critical, especially for first-line providers interpreting ECGs, as it may prevent SCD.
- 2 March 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 10 (3)
Open AccessUnmasking Brugada syndrome: a case report of diagnostic oversights
Background: Brugada syndrome (BrS) is an unusual cardiac channelopathy associated with an increased risk of ventricular fibrillation (VF) and sudden cardiac death (SCD), highlighting the critical importance of early diagnosis. Case summary: A 22-year-old male patient presented with recurrent episodes of syncope, palpitations, and dyspnoea. Initial electrocardiograms (ECGs) showing a Brugada Type 1 pattern were misinterpreted as incomplete right bundle branch blocks. The patient was erroneously diagnosed with epilepsy due to misinterpretation of his syncope episodes as seizures. After further investigations, including a propafenone provocation test and cardiac magnetic resonance imaging (MRI), BrS was confirmed. An electrophysiologic study showed no inducibility of ventricular tachycardia (VT) or VF, and a subcutaneous implantable cardioverter-defibrillator (S-ICD) was implanted for the prevention of SCD. The patient’s recovery was successful and uncomplicated. Discussion: Brugada syndrome patients usually present with SCD, syncope, or severe arrhythmias. Syncope is the most common clinical presentation and identifies patients who could benefit from ICD. Only the Type 1 Brugada pattern is diagnostic, either spontaneous, unmasked by high precordial leads, or by sodium channel inhibition. Implantable cardioverter-defibrillator placement is indicated to prevent SCD. A subcutaneous defibrillator should be considered if the patient has no need for anti-bradyarrhythmia pacing. Conclusion: Early recognition of BrS in patients with syncope is critical, especially for first-line providers interpreting ECGs, as it may prevent SCD.
- Open Access
- 9 February 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (2) , 84
Multimodality Imaging in Cardiac Metastasis of Cutaneous Melanoma: Case Report and Systematic Review
Background: Cardiac metastases from cutaneous melanoma are uncommon and often underdiagnosed due to their variable and frequently asymptomatic presentation. To better describe their clinical features, diagnostic strategies, and outcomes, we performed a systematic review of published case reports and present an illustrative clinical case. Case presentation: We report the case of a 67-year-old man with a history of stage IIA cutaneous melanoma who presented with progressive fatigue and dyspnea. Disease recurrence was confirmed by skin biopsy. Multimodal imaging, including echocardiography, FDG PET-CT, and cardiac magnetic resonance (CMR), demonstrated extensive myocardial infiltration consistent with cardiac metastases. Despite treatment with immunotherapy, the patient experienced progressive clinical deterioration and died six months after diagnosis. Discussion: The systematic review encompassed 23 published articles reporting 27 individual cases, with a mean age at diagnosis of 55.9 years and a clear male predominance. Cardiac involvement exhibited marked heterogeneity in both clinical presentation and anatomical distribution, most frequently affecting the left ventricular free wall and the interventricular septum. Echocardiography consistently served as the initial diagnostic modality, while cardiac magnetic resonance and CT/FDG PET-CT were used to refine lesion characterization and assess extracardiac disease. Notably, a complete multimodal imaging strategy was reported in fewer than one-third of cases, reflecting variability in diagnostic approaches. Survival outcomes were highly heterogeneous, with substantial mortality, underscoring the need for earlier detection and more accurate diagnostic strategies for cardiac involvement in melanoma. Conclusions: Cardiac metastases from melanoma represent advanced disease and remain associated with poor and heterogeneous outcomes. An integrated multimodal imaging approach supports detailed diagnostic characterization and may aid clinical evaluation and management in selected cases.
- 9 February 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (2) , 84
Open AccessMultimodality Imaging in Cardiac Metastasis of Cutaneous Melanoma: Case Report and Systematic Review
Background: Cardiac metastases from cutaneous melanoma are uncommon and often underdiagnosed due to their variable and frequently asymptomatic presentation. To better describe their clinical features, diagnostic strategies, and outcomes, we performed a systematic review of published case reports and present an illustrative clinical case. Case presentation: We report the case of a 67-year-old man with a history of stage IIA cutaneous melanoma who presented with progressive fatigue and dyspnea. Disease recurrence was confirmed by skin biopsy. Multimodal imaging, including echocardiography, FDG PET-CT, and cardiac magnetic resonance (CMR), demonstrated extensive myocardial infiltration consistent with cardiac metastases. Despite treatment with immunotherapy, the patient experienced progressive clinical deterioration and died six months after diagnosis. Discussion: The systematic review encompassed 23 published articles reporting 27 individual cases, with a mean age at diagnosis of 55.9 years and a clear male predominance. Cardiac involvement exhibited marked heterogeneity in both clinical presentation and anatomical distribution, most frequently affecting the left ventricular free wall and the interventricular septum. Echocardiography consistently served as the initial diagnostic modality, while cardiac magnetic resonance and CT/FDG PET-CT were used to refine lesion characterization and assess extracardiac disease. Notably, a complete multimodal imaging strategy was reported in fewer than one-third of cases, reflecting variability in diagnostic approaches. Survival outcomes were highly heterogeneous, with substantial mortality, underscoring the need for earlier detection and more accurate diagnostic strategies for cardiac involvement in melanoma. Conclusions: Cardiac metastases from melanoma represent advanced disease and remain associated with poor and heterogeneous outcomes. An integrated multimodal imaging approach supports detailed diagnostic characterization and may aid clinical evaluation and management in selected cases.
- Open Access
- 23 September 2025
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 12 (10) , 375
Clinical Applications of Cardiac Computed Tomography: A Focused Review for the Clinical Cardiologists
Cardiac computed tomography (CT) has become a cornerstone in the non-invasive evaluation and management of cardiovascular disease, offering clinicians detailed anatomical and functional information that directly influences patient care. This review focuses on three primary clinical applications: coronary artery calcium (CAC) scoring, coronary CT angiography (CCTA), and preprocedural planning for structural heart interventions. CAC quantification remains one of the most powerful prognostic tools for cardiovascular risk stratification, with robust evidence supporting its use in asymptomatic and selected symptomatic individuals. CCTA provides a high-resolution assessment of coronary anatomy and plaque characteristics, guiding both preventive and acute care strategies. In structural heart disease, CT is indispensable for accurate device sizing, procedural planning, and complication avoidance in interventions such as transcatheter valve replacement or repair. Beyond these core applications, cardiac CT supports the evaluation of pericardial, myocardial, aortic, and congenital heart disease, and plays a role in pulmonary embolism risk assessment. Technological innovations—including artificial intelligence, dual-energy imaging, and photon-counting CT—are enhancing image quality, reducing radiation exposure, and broadening the modality’s prognostic capabilities. Collectively, these advances are solidifying cardiac CT as an integrated diagnostic and planning tool with a significant impact on clinical decision-making and patient outcomes.
- 23 September 2025
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 12 (10) , 375
Open AccessClinical Applications of Cardiac Computed Tomography: A Focused Review for the Clinical Cardiologists
Cardiac computed tomography (CT) has become a cornerstone in the non-invasive evaluation and management of cardiovascular disease, offering clinicians detailed anatomical and functional information that directly influences patient care. This review focuses on three primary clinical applications: coronary artery calcium (CAC) scoring, coronary CT angiography (CCTA), and preprocedural planning for structural heart interventions. CAC quantification remains one of the most powerful prognostic tools for cardiovascular risk stratification, with robust evidence supporting its use in asymptomatic and selected symptomatic individuals. CCTA provides a high-resolution assessment of coronary anatomy and plaque characteristics, guiding both preventive and acute care strategies. In structural heart disease, CT is indispensable for accurate device sizing, procedural planning, and complication avoidance in interventions such as transcatheter valve replacement or repair. Beyond these core applications, cardiac CT supports the evaluation of pericardial, myocardial, aortic, and congenital heart disease, and plays a role in pulmonary embolism risk assessment. Technological innovations—including artificial intelligence, dual-energy imaging, and photon-counting CT—are enhancing image quality, reducing radiation exposure, and broadening the modality’s prognostic capabilities. Collectively, these advances are solidifying cardiac CT as an integrated diagnostic and planning tool with a significant impact on clinical decision-making and patient outcomes.
- 14 November 2024
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 105 (2) , 308-320
Diagnostic Performance of Quantitative Flow Ratio for the Assessment of Non‐Culprit Lesions in Myocardial Infarction (QFR‐OUTSMART): Systematic Review and Meta‐Analysis
Background: Quantitative flow ratio (QFR) analysis is a simple and non‐invasive coronary physiological assessment method with evidence for evaluating stable coronary artery disease with correlation to fractional flow reserve (FFR). However, there is no evidence to recommend its use in non‐culprit lesions (NCLs) in myocardial infarction (MI).Methods: We performed a systematic review and meta‐analysis using the PRISMA and PROSPERO statements. The study's primary objective was to assess the diagnostic accuracy of QFR in identifying functionally significant NCLs after MI based on invasive FFR and non‐hyperemic pressure ratios as references. We obtained values of the area under the curve (AUC), sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). We performed a leave‐one‐out sensitivity analysis for each study's impact on the overall effect.Results: We included eight studies, with 713 patients and 920 vessels evaluated with QFR. The overall AUC was 0.941 (I2 = 0.559, p < 0.002), with a sensitivity of 87.3%, a specificity of 89.4%, a PPV of 86.6%, and an NPV of 90.1%. Compared to FFR, we found an AUC of 0.957 (I2 = 0.331, p < 0.194), a sensitivity of 89.6%, a specificity of 89.8%, a PPV of 88.3%, and an NPV of 91%. The sensitivity analysis showed a similar diagnostic performance in both studies.Conclusions: QFR is effective in analyzing NCLs with a significant diagnostic yield compared to FFR, with an excellent AUC in MI patients. Performing prospective multicenter studies to characterize this population and reproduce our results is essential.
- 14 November 2024
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 105 (2) , 308-320
Diagnostic Performance of Quantitative Flow Ratio for the Assessment of Non‐Culprit Lesions in Myocardial Infarction (QFR‐OUTSMART): Systematic Review and Meta‐Analysis
Background: Quantitative flow ratio (QFR) analysis is a simple and non‐invasive coronary physiological assessment method with evidence for evaluating stable coronary artery disease with correlation to fractional flow reserve (FFR). However, there is no evidence to recommend its use in non‐culprit lesions (NCLs) in myocardial infarction (MI).Methods: We performed a systematic review and meta‐analysis using the PRISMA and PROSPERO statements. The study's primary objective was to assess the diagnostic accuracy of QFR in identifying functionally significant NCLs after MI based on invasive FFR and non‐hyperemic pressure ratios as references. We obtained values of the area under the curve (AUC), sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). We performed a leave‐one‐out sensitivity analysis for each study's impact on the overall effect.Results: We included eight studies, with 713 patients and 920 vessels evaluated with QFR. The overall AUC was 0.941 (I2 = 0.559, p < 0.002), with a sensitivity of 87.3%, a specificity of 89.4%, a PPV of 86.6%, and an NPV of 90.1%. Compared to FFR, we found an AUC of 0.957 (I2 = 0.331, p < 0.194), a sensitivity of 89.6%, a specificity of 89.8%, a PPV of 88.3%, and an NPV of 91%. The sensitivity analysis showed a similar diagnostic performance in both studies.Conclusions: QFR is effective in analyzing NCLs with a significant diagnostic yield compared to FFR, with an excellent AUC in MI patients. Performing prospective multicenter studies to characterize this population and reproduce our results is essential.
- 16 October 2021
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 37 (12) , 3589-3590
Computed tomography derived left ventricular inward displacement as a novel tool for quantification of segmental wall motion abnormalities
- 16 October 2021
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 37 (12) , 3589-3590
Computed tomography derived left ventricular inward displacement as a novel tool for quantification of segmental wall motion abnormalities
- 1 February 2008
- Published by Elsevier in European Journal of Radiology
- Vol. 65 (2) , 316-325
A multi-center, comparative, phase 3 study to determine the efficacy of gadofosveset-enhanced magnetic resonance angiography for evaluation of renal artery disease
- 1 February 2008
- Published by Elsevier in European Journal of Radiology
- Vol. 65 (2) , 316-325
A multi-center, comparative, phase 3 study to determine the efficacy of gadofosveset-enhanced magnetic resonance angiography for evaluation of renal artery disease